Skip to main content
Healthcare

STAT+: AstraZeneca opens new Boston site 

STAT+: AstraZeneca opens new Boston site 

Feed excerpt — reported by STAT News

AstraZeneca opened a new R&D site in Kendall Square yesterday, celebrating a $1 billion investment in the unsettled center of U.S. biotechnology after a spate of Chinese dealmaking.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →

Original Source

This article was syndicated from STAT News. All rights remain with the original publisher.